Back to News

otcstockexchange.com: UPZS, MGMX, PTSC, XKEM OTCStockExchange.com Stock Alert

Rochester, NY, Jun 05, 2006 (M2 PRESSWIRE via COMTEX) -- OTCStockExchange.com's "Stock Watch Alert" this morning are Unique Pizza and Subs Corporation (Pink Sheets: UPZS), Metro Gold Mines Mineral Resources Inc. (Pink Sheets: MGMX), Patriot Scientific Corporation (OTCBB: PTSC), Xechem International, Inc. (OTCBB: XKEM).
Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com !

Unique Pizza and Subs Corporation (Pink Sheets: UPZS - http://finance.yahoo.com/q?s=UPZS.PK ) Unique Pizza and Subs Corporation, a Delaware Corporation, has begun to expand its presence in its home market of Pittsburgh, Pennsylvania. Over the next 60 days, Unique Pizza and Subs will be opening three new locations in Monaca, Wexford and Robinson Township. Unique Pizza and Subs is in various stages of negotiations with numerous prospective franchisees throughout Western Pennsylvania. Unique Pizza and Subs is projecting the opening of 6 (six) new stores and 25 (twenty-five) independent stores converted to UPZSs by the end of 2007 with total sales of $13,285,300.

James Vowler, President and CEO of Unique Pizza and Subs, stated, "As the only publicly traded pizza franchise that is headquartered in Pittsburgh, we are extremely excited about our growth throughout Western Pennsylvania. I designed Unique Pizza and Subs from its conception to be a publicly traded, nationwide franchise. A franchise that would have the quality of a 'mom-and-pop' pizza shop but with the consistency of a major franchise. According to Pizza Today Magazine; 'Western PA has more pizza shops per capita than any other area in the U.S.,' which has made it the perfect market for us to showcase our success. Over the last 15 years, we have won many awards, we have been the official pizzas of the Pittsburgh Penguins and Riverhounds, but our biggest success is the intense loyalty of our customers in the Pittsburgh market. With the addition of thirty-one new locations throughout Western Pennsylvania, it is just another of many strong indications to our shareholders how committed we are to becoming one of the top ten pizza franchises in the U.S."

The Pittsburgh market will allow Unique Pizza and Subs to demonstrate the tremendous benefits of building an experienced and talented management team. This executive team assembled by President and CEO, James Vowler, has produced a powerfully strategic business model that will strengthen market share, acquire new franchisees rapidly, and dominate a competitive market like Pittsburgh. Unique Pizza and Subs thrives on competition because no other national franchise can produce the quality of a "mom-and-pop" pizzeria while maintaining the consistency and strength of a major franchise.

Unique Pizza and Subs has many advantages over the competition (superior product, a unique and extensive menu, a Customer Response Center) but the main focus of the investment community is UPZS's ability to grow rapidly in any market. Given that Unique Pizza and Subs rapid growth is not limited by demographics or household incomes, it is making the brokerage firms and individual investors take notice. All of these factors are proof of UPZS's commitment towards national expansion and dedication to building value for their shareholders. Other new markets scheduled for opening this summer are: Atlanta, GA; Austin, TX; Boston, MA; Milwaukee, WI; and Norfolk, VA.

About Unique Pizza and Subs Corporation, a Delaware Corporation

Unique Pizza and Subs Corporation currently is a startup/development stage company. Jim Vowler, President and CEO, completed four years of research before opening his first pizza restaurant in Millvale, PA and then spent the next eleven years refining every aspect of the pizza business and was responsible for opening more than 20 locations under the name Unique Pizza Factory Corporation. Mr. Vowler's pizzas were the official pizzas of the Pittsburgh Penguins and won numerous awards for taste and quality. Calling on this experience, Mr. Vowler has assembled an experienced management team to further develop the company's unique, quality products and business model that is well positioned for rapid growth.

Metro Gold Mines Mineral Resources Inc. (Pink Sheets: MGMX - http://finance.yahoo.com/q?s=MGMX.PK ) Metro Gold Mines Mineral Resources Inc., a growing gold mining company engaged in the acquisition and development of production properties in South and Central America, has expanded operations by opening new offices, launching a new corporate website, while moving forward with La Esperanza and Manantiales properties.

"We have been overwhelmed over the last few weeks," said Kenneth Lamb, President of MGM Mineral Resources. "Due to many ongoing aspects of our business and the exciting developments on our properties, we neglected some of our administration duties. These are all symptoms of growing pains from a Company that is rapidly expanding. We feel that we have addressed these issues and now our team is ready to help create shareholder value. I feel our shareholders will be pleasantly surprised when our full story unfolds over the course of the next few months."

MGM Mineral Resources has established corporate operations in both Colombia and North America. The company can be contacted at its offices in the following locations:

North American Office 1 YONGE STREET SUITE 1801 TORONTO, ONTARIO M5E 1W7 TEL 416-214-7847

Colombian Office CARRERA 46 # 7 - 227 MEDELLIN, COLOMBIA TEL 574-325-7818

The company has also launched a new website, which can be viewed at: www.mgmmining.com

The new site offers expanded functionality and the latest information regarding new acquisitions, current operations, management, corporate objectives and the rich gold zone in Colombia where MGM Mineral Resources is mining.

In addition, the company continues to work with Pink Sheets in order to resume quotation services on Pink Sheets. Mr. Lamb continues, "All information has been filed, translated and finalized in attempts to reach full quoting status on Pink Sheets. Unfortunately due to the abuses of certain shareholders we have been put in a position of going above and beyond the norm in regards to disclosure. As a company, we are fine with this and will apply this higher standard in all our future correspondences with shareholders and with the investment community. This will only strengthen our visibility of being a Company committed to building shareholder value and in becoming a responsible and respected issuer."

Such things have not stopped the Company from their onwards push to success, as they have continued updating the 15C211 form and can be found listed on Pink Sheets. In fact, they have posted the first quarter results from 2006.

"Based on our constant updates of the 15C211, our shareholders will see that Metro Gold Mines is immersed in operations. Our Company is finalizing all property negotiations, while attaining and securing the necessary mining permits with Manantiales," said Jairo Giraldo, C.E.O. "We would like to complete the transaction and turn the Letter of Intent into a confirmed acquisition." Mr. Giraldo added that the transaction will be completed within the week.

There are also additional administrative changes that have occurred within the company pertaining to new staff. This includes finalizing a contract with another highly experienced, well-renowned Geologist to work on the present mines, as well as all future acquisitions. Specific information will be released when the contract is secured.

"We are growing rapidly," said Kenneth Lamb. "Establishing international operations, executing marketing programs including the creation of a leading edge website are just a few of the objectives we have outlined in our growth strategy. These accomplishments will enable us to increase productivity, streamline operations and communicate more effectively with shareholders."

Patriot Scientific Corporation (OTCBB: PTSC - http://finance.yahoo.com/q?s=PTSC.OB ) Patriot Scientific Corporation engages in the development, marketing, and sale of microprocessors, technology for microprocessors, and complementary products that enable computers and other data processing devices to communicate. The company develops its microprocessor technology for various applications in wireless devices, smart cards, home appliances, and gateways, as well as in set top boxes, entertainment technology, automotive telematics, biomedical devices, and industrial controllers in the United States. It also has a patent for special radar technology, which would allow a licensee to penetrate the ground or structures to find various objects.

Xechem International, Inc. (OTCBB: XKEM - http://finance.yahoo.com/q?s=XKEM.OB ) Xechem International, Inc. announced that its Nigerian subsidiary, Xechem Pharmaceuticals Nigeria Ltd. (Xechem Nigeria), has successfully closed on a N150 Million Naira ($1.2 million) loan from the Nigerian Export-Import (NEXIM) Bank. The loan has a three year term, with a moratorium on repayment of principal during the first year. Xechem International is neither a borrower nor a guarantor under the loan facility in this transaction.

Proceeds Earmarked For Expanding Production Facility For NICOSAN(TM) In Abuja

The money received by Xechem Nigeria is to be used primarily to facilitate the expansion of its facility for the commercial scale production of NICOSAN(TM), its promising Sickle Cell drug. At the signing ceremony held at NEXIM's headquarters in Abuja, Nigeria, Dr. Ramesh Pandey, Chairman and CEO of both Xechem International and Xechem Nigeria, said, "The loan will enable the company to immediately begin construction of buildings needed to expand its commercial scale production facility in Abuja. It is a proud moment not only for Xechem Nigeria, but for the whole of Nigeria as well. By taking this giant step with us, NEXIM Bank has confirmed to the world the great confidence it has in this project. This will not only accelerate Xechem's efforts in bringing NICOSAN(TM) to the market, but will also help build international esteem for Nigeria and the changing investment climate in that country. We are extremely gratified that we can now embark on our much needed expansion, and are particularly excited that we can do so with locally generated funds from a respected and reputable local bank." The Chairman of NEXIM Bank, who is also Deputy Governor of Central Bank of Nigeria, Mr. Tunde Lemo, complimented Xechem for coming to Nigeria and setting up the facility to produce NICOSAN(TM) to treat an African disease for which there is no drug in the market.

Speaking of the dignitaries in attendance at the signing ceremony, Dr. Pandey added: "I am very pleased and happy to see Professor A.B.C. Nwosu, the former Honorable Health Minister, at this ceremony. It was during his tenure that Xechem obtained the exclusive worldwide license for NICOSAN(TM) from the National Institute for Pharmaceutical Research and Development (NIPRD). I am also honored to see among those in attendance the Hon. Prof. Turner Isoun, Nigeria's Minister of Science and Technology. From the beginning, he has been extremely supportive of our efforts and we are forever grateful for the interest he has taken in what we are doing in Nigeria."

Among the other dignitaries present at the May 22nd signing ceremony at NEXIM Bank building in Abuja were: MD & CEO of NEXIM Bank, Alhaji Baba Yusuf Ahmed; The Minister of State for Finance (represented); The Director General of Sheda Science & Technology, Dr. Ayo Coker; Mr. Alhaji Tijani, Director General & CEO of Abuja Development Corporation, representing The Chairman of the Federal Capitol of Nigeria.

Drug To Be Launched In Nigeria Following NAFDAC Approval.

As previously reported by Xechem International, Xechem Nigeria has submitted its Drug Master File (DMF) dossier with Nigeria's drug regulatory agency, the National Agency for Food and Drug Administration and Control (NAFDAC), seeking full registration for NICOSAN(TM). It is currently awaiting final word from that agency on its submission. Subject to the necessary approvals, Xechem has indicated that it would like to launch the drug in Nigeria by early July 2006, and shortly thereafter to embark on the clinical trials in the US hospitals for FDA approval through the Investigational New Drug (IND) Application for sale of the drug in the United States.

About OTCStockExchange.com

OTCStockExchange.com (OTCS) is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. OTCS is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. OTCS's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. OTCS provides all investors with the latest news, press releases, investment opinions, and research reports for all the companies highlighted on the site. OTCS offers a free financial newsletter. To subscribe or get more information, visit our home page located at http://www.otcstockexchange.com .

We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Chris Wheeler at 585-330-8514 , or via email at info@otcstockexchange.com .

OTCStockExchange.com (OTCS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by OTCS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.otcstockexchange.com or mentioned herein. OTCS has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion.

Affiliates of the publisher for OTCS are to receive a cash fee of five thousand dollars and 71,429 free-trading shares from a third party shareholder of Unique Pizza and Subs Corporation (UPZS) for this investment opinion feature, and may furthermore buy shares in open market transactions or sell any such shares so acquired at any time, either before, during, our after the publication of this website feature. OTCS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and OTCS undertakes no obligation to update such statements.

CONTACT: Chris Wheeler Tel: +1 585 330 8514 e-mail: info@otcstockexchange.com WWW: http://www.otcstockexchange.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

(C)1994-2006 M2 COMMUNICATIONS LTD

**********************************************************************
As of Thursday, 06-01-2006 23:59, the latest Comtex SmarTrend(SM) Alert, an automated pattern recognition system, indicated an UPTREND on 04-25-2006 for PTSC @ $1.31.

(C) 2006 Comtex News Network, Inc. All rights reserved.

-0-